HealthTree Logo
search more_vert
close
person Sign In / Create Account

Clinical Expertise

  • Hematopoietic growth factor receptors
  • Murine models of graft-versus-host disease and graft-versus-leukemia
  • Leukemia genomics

About

Dr. John F. DiPersio, Deputy Director, Alvin J. Siteman Cancer Center and Chief of the Division of Oncology at Washington University School of Medicine in St. Louis and the Virginia E. and Samuel J. Golman Professor of Medicine.

Dr. DiPersio’s research focuses on fundamental and translational aspects of leukemia and stem cell biology. These studies include identification of genetic abnormalities in human leukemias, understanding processes involving stem cell and leukemia cell trafficking, and clinical and translational programs in both leukemia/myelodysplastic syndrome and transplantation immunology.

Among his many accomplishments, Dr. DiPersio was instrumental in developing a drug called plerixafor and ruxolitnib in 2019 that were approved by the U.S. Food and Drug Administration in 2008 and 2019 respectively for the treatment of multiple myeloma, non-Hodgkin’s lymphoma and graft versus host disease.

Location

Washington University School Of Medicine: 660 S Euclid Ave, St. Louis, MO 63110, USA

Get the latest thought leadership on Acute Myeloid Leukemia delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Acute Myeloid Leukemia Newsletter" for Acute Myeloid Leukemia news, life with Acute Myeloid Leukemia stories, Acute Myeloid Leukemia clinical trials, Acute Myeloid Leukemia 101 articles and events with Acute Myeloid Leukemia experts.

Thanks to our HealthTree Community for Acute Myeloid Leukemia Sponsors:

Abbvie
Astellas Pharma
Servier

Follow Us

facebook instagram youtube